OPTIBIOTIX HEALTH PLC Logo

OPTIBIOTIX HEALTH PLC

Develops microbiome-modulating ingredients and supplements to manage chronic lifestyle diseases.

OPTI | IL

Overview

Corporate Details

ISIN(s):
GB00BP0RTP38
LEI:
213800UKYQFT941QHS14
Country:
United Kingdom
Address:
Innovation Centre Innovation Way, YO10 5DG York
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

OptiBiotix Health PLC is a life sciences company specializing in the research and development of technologies that modulate the human microbiome. The company identifies and develops microbial strains, compounds, and formulations for use as food ingredients and supplements. Its core focus is on the prevention and management of chronic lifestyle diseases, including obesity, hypercholesterolemia (high cholesterol), and diabetes. The company's approach is underpinned by scientific research and human clinical studies, delivering proprietary ingredients like SlimBiome® and LPLDL® as well as white-label product solutions to its commercial partners.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-02 08:00
Director's Dealing
Director/PDMR Shareholding
English 33.8 KB
2025-09-24 13:28
Director's Dealing
Director/PDMR Shareholding
English 43.8 KB
2025-09-16 08:00
Interim Report
Half-year Report
English 230.4 KB
2025-08-21 08:00
Delisting Announcement
Admission to Trading on the OTCQB Venture Market
English 14.4 KB
2025-08-20 08:00
Regulatory News Service
Agreement with Weight Management Company
English 15.1 KB
2025-08-14 08:00
Regulatory News Service
Launch of SlimBiome in leading US brand
English 17.0 KB
2025-08-06 17:08
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
English 13.9 KB
2025-08-06 08:00
Share Issue/Capital Change
Issue of Options
English 31.2 KB
2025-07-28 08:00
Earnings Release
Trading update
English 19.1 KB
2025-06-30 08:00
Earnings Release
Final Results
English 544.3 KB
2025-06-30 08:00
Regulatory News Service
Change of Broker
English 11.6 KB
2025-06-11 08:00
Environmental & Social Information
SlimBiome® study in European Journal of Nutrition
English 28.0 KB
2025-05-23 08:00
Share Issue/Capital Change
Placing and Issue of Warrants
English 20.6 KB
2025-03-18 08:00
Business and Financial Review
Commercial Update
English 35.7 KB
2025-02-18 08:00
Regulatory News Service
Launch of Daily Nouri FeelFull product in America
English 18.4 KB

Automate Your Workflow. Get a real-time feed of all OPTIBIOTIX HEALTH PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for OPTIBIOTIX HEALTH PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
FARON PHARMACEUTICALS OY Logo
Develops myeloid cell-targeting immunotherapies for solid and hematological cancers.
Finland FARN
Fluicell AB Logo
Developing bioprinted tissues for regenerative medicine and advanced drug screening.
Sweden FLUI
FluoGuide A/S Logo
Develops fluorescent drugs to guide surgeons for more precise cancer removal and patient outcomes.
Denmark FLUO
FUSION ANTIBODIES PLC Logo
A CRO providing end-to-end antibody engineering services for therapeutic & diagnostic development.
United Kingdom FAB
FUTURA MEDICAL PLC Logo
Develops topical sexual health gels, including a fast-acting, over-the-counter ED treatment.
United Kingdom FUM
GENINCODE PLC Logo
AI-powered genetic tests for physicians, predicting and preventing cardiovascular disease.
United Kingdom GENI
Genomic Vision Logo
Develops DNA analysis tools using Molecular Combing for genetic research and diagnostics.
France GV
Genxone Spolka Akcyjna Logo
A biotech firm offering nanopore DNA/RNA sequencing services and medical diagnostics.
Poland GX1
Hamlet BioPharma AB Logo
Developing selective therapies for cancer and infections like bladder cancer and UTIs.
Sweden HAMLET
Hipower Energy Spolka Akcyjna Logo
Develops hydrogen solutions, mobile refueling, and CO2-to-methanol tech for energy markets.
Poland HPE

Talk to a Data Expert

Have a question? We'll get back to you promptly.